DUBLIN--(BUSINESS WIRE)--The "Lumpectomy Market in US 2022-2026" report has been added to ResearchAndMarkets.com's offering.
The lumpectomy market in the US is poised to grow by $1.08 bn during 2022-2026 progressing at a CAGR of 5.44%
The market is driven by the growing incidence of new breast cancer cases, government initiatives to increase public awareness about breast cancer, and strategy to raise public funding for breast cancer research.
The report on the lumpectomy market in US provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current country market scenario, latest trends and drivers, and the overall market environment. The lumpectomy market in US analysis includes the end-user and product segments.
This study identifies the presence of venture capitalists as one of the prime reasons driving the lumpectomy market growth in US during the next few years. Also, focus on technologies and the emergence of integrated breast cancer treatment centers will lead to sizable demand in the market.
The publisher's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading lumpectomy market vendors in US that include Becton Dickinson and Co., Carl Zeiss AG, ClearCut Medical, Dilon Medical Technologies Inc., Endomagnetics Ltd., Hologic Inc., iCAD Inc., IceCure Medical, Innoblative Designs Inc., Medtronic Plc, Merit Medical Systems Inc., Novian Health, and Vector Surgical LLC Inc.
Also, the lumpectomy market in US analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
Key Topics Covered:
1 Executive Summary
1.1 Market overview
2 Market Landscape
2.1 Market ecosystem
3 Market Sizing
3.1 Market definition
3.2 Market segment analysis
3.3 Market size 2021
3.4 Market outlook: Forecast for 2021-2026
4 Five Forces Analysis
4.1 Five forces summary
4.2 Bargaining power of buyers
4.3 Bargaining power of suppliers
4.4 Threat of new entrants
4.5 Threat of substitutes
4.6 Threat of rivalry
4.7 Market condition
5 Market Segmentation by End-user
5.1 Market segments
5.2 Comparison by End-user
5.3 ASCs - Market size and forecast 2021-2026
5.4 Hospitals - Market size and forecast 2021-2026
5.5 Market opportunity by End-user
6 Market Segmentation by Product
6.1 Market segments
6.2 Comparison by Product
6.3 Lumpectomy systems - Market size and forecast 2021-2026
6.4 Lumpectomy surgical tools - Market size and forecast 2021-2026
6.5 Market opportunity by Product
7 Customer Landscape
7.1 Customer landscape overview
8 Drivers, Challenges, and Trends
8.1 Market drivers
8.2 Market challenges
8.3 Impact of drivers and challenges
8.4 Market trends
9 Vendor Landscape
9.1 Overview
9.2 Vendor landscape
9.3 Landscape disruption
9.4 Industry risks
10 Vendor Analysis
10.1 Vendors covered
10.2 Market positioning of vendors
- Becton Dickinson and Co.
- Carl Zeiss AG
- ClearCut Medical
- Dilon Medical Technologies Inc.
- Endomagnetics Ltd.
- Hologic Inc.
- iCAD Inc.
- IceCure Medical
- Innoblative Designs Inc.
- Medtronic Plc
- Merit Medical Systems Inc.
- Novian Health
- Vector Surgical LLC Inc.
For more information about this report visit https://www.researchandmarkets.com/r/hhap6i
